Vakrangee Ltd.

Vakrangee is currently trading at Rs. 40.75, up by 0.20 points or 0.49% from its previous closing of Rs. 40.55 on the BSE.

The scrip opened at Rs. 38.55 and has touched a high and low of Rs. 40.85 and Rs. 38.55 respectively. So far 2380823 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 69.85 on 31-Dec-2020 and a 52 week low of Rs. 24.40 on 24-Sep-2020.

Last one week high and low of the scrip stood at Rs. 48.75 and Rs. 40.85 respectively. The current market cap of the company is Rs. 4295.89 crore.

The promoters holding in the company stood at 42.60%, while Institutions and Non-Institutions held 16.03% and 41.36% respectively.

Vakrangee has launched a Comprehensive COVID care plan in partnership with vHealth by Aetna, a CVS Pharmacy Group Company – Fortune 500 Company. The 'Comprehensive Covid Care Package' includes various tests and consultations which can be used to determine if a patient is likely to have COVID infection. It includes Key features such as Home collection of COVID-19 RT-PCR test as well as COVID Monitor test facility.

COVID monitoring test helps to keep a check on various health parameters, ideal for those who recently been diagnosed with COVID-19 infection or have already recovered. It includes monitoring of key parameters such as Complete Blood count (CBC), C-reactive Protein (CRP), Lactic acid Dehydrogenas (LDH), Kidney Function test (KFT), and Liver Function test (LFT). Currently, to start with, the service has been made available in Tier 1 cities across the country.

Vakrangee is the unique technology driven company focused on building India's largest network of last mile retail outlets to deliver real time banking & Financial Services, ATM, insurance, e-governance, ecommerce and logistics services to the un-served rural, semi-urban and urban markets.